Paul Brennan, PhD
Co-founder, non-exec Board Member
Paul has over 25 years of experiece in drug discovery and medicinal chemistry.
He serves as Director of the Centre for Medicines Discovery at the University of Oxford.
Prior to his academic leadership roles, Paul was a Senior Principal Scientist at Pfizer and a Senior Scientist at Amgen, focusing on small molecule drug discovery.
He completed postdoctoral research at University of Cambridge and holds a Ph.D. in Organic Chemistry from University of California, Berkeley.